Patent · US Active

Methods of determining patient response by measurement of HER-3 and P95

US9766242B2 · kind B2 · utility

3Cited by
74References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 17, 2015
Grant dateSep 19, 2017
Priority date
Expiry dateJul 17, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/54
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

The invention provides methods of measuring and/or quantifying the presence and/or amount of Her-3 and/or Her-3 in a complex and the presence and/or amount of p95 in a sample. The invention also provides antibodies specific for Her-3.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.